The average one-year price target for Armata Pharmaceuticals (NYSEAM:ARMP) has been revised to $17.85 / share. This is an ...

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It ...

The price trend for Armata Pharmaceuticals, Inc. (ARMP) has been bearish lately and the stock has lost 5.6% over the past four weeks. However, the formation of a hammer chart pattern in its last ...

Armata Pharmaceuticals, Inc. (NYSEAM:ARMP) is among the most promising stocks. On February 23, 2026, H.C. Wainwright increased the price target for ARMP from $9.00 to $15.00 and kept a Buy rating on ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Armata Pharmaceuticals, Inc. (ARMP) is a stock that can ...

Armata Pharmaceuticals Inc. Annual stock financials by MarketWatch. View the latest ARMP financial statements, income statements and financial ratios.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.